Treatment for Autism

Phase-Based Progress Estimates
3
Effectiveness
3
Safety
Autism+2 More
Eligibility
6 - 12
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test the effect of Lisdexamfetamine dimesylate on children and adolescents with ADHD and comorbid Autism Spectrum Disorder.

Eligible Conditions
  • Autism
  • Attention Deficit Hyperactivity Disorder (ADHD)

Treatment Effectiveness

Study Objectives

1 Primary · 6 Secondary · Reporting Duration: 12 weeks

12 weeks
ADHD Symptoms
Executive Function
Health Related Quality of Life
Improvement of Subjects
Safety - suicidality
Safety-Adverse events
Severity of illness

Trial Safety

Trial Design

0 Treatment Group

40 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · Phase 4

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 12 weeks

Who is running the clinical trial?

ShireIndustry Sponsor
455 Previous Clinical Trials
93,049 Total Patients Enrolled
JPM van Stralen Medicine ProfessionalLead Sponsor
2 Previous Clinical Trials
79 Total Patients Enrolled
Judy van Stralen, MDPrincipal InvestigatorCenter for Pediatric Excellence
1 Previous Clinical Trials
29 Total Patients Enrolled

Eligibility Criteria

Age 6 - 12 · All Participants · 8 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Who else is applying?

How old are they?
18 - 65100.0%
What site did they apply to?
Center for Pediatric Excellence100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%
How many prior treatments have patients received?
3+100.0%
References